Trial Site Detail

 

Drug:
Dasatinib (BMS-354825)
Trial:
Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Ongoing, but not recruiting

 

Onkozentrum - Klinik im Park

     
Zurich , CH-8002
Switzerland

 

Principal Investigator:
Contact:
41-43-344-3333
Activation Status of this Site:
Closed
Notes about this Site:
Onkozentrum - Klinik im Park Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.